- 2024,04,27
Recently, a batch of trucks carrying pure natural glucosamine hydrochloride (hereinafter referred to as "aminosugar") raw materials slowly drove into the factory area. Fujian Huakang Pharmaceutical Co., Ltd., a subsidiary of Zheng Cheng Yi Pharmaceutical Co., Ltd. (hereinafter referred to as "Cheng Yi Pharmaceutical"), has the approval to produce pharmaceutical grade aminosugar raw materials and is supplying its parent company or other pharmaceutical companies with pure natural aminosugar raw materials to meet the demand for high-quality "green aminosugar" raw materials in domestic and foreign markets.
On December 5, 2023, Cheng Yi Pharmaceutical participated in the 87th National Drug Fair in Guangzhou
To welcome the arrival of the national "silver economy" era, Cheng Yi Pharmaceutical has built a "big health product matrix" that adapts to various health problems of middle-aged and elderly people, and is undergoing market testing. To prevent and treat osteoarthritis in the middle-aged and elderly population, the company has developed a pure natural "green amino sugar" product that has steadily ranked among the top clinical sales in the country; To treat acute and chronic cholecystitis, biliary tract infections, gallbladder and biliary stones in patients of all ages, the company has launched the "Dan Yi Ning" tablet, which is an exclusive traditional Chinese medicine variety in the country; To solve the cardiovascular and cerebrovascular problems, especially hyperlipidemia, among the middle-aged and elderly population, the company has launched a series of ultra-high purity fish oil EPA soft capsules; In order to improve the immunity of the middle-aged and elderly population, the company has launched a series of nerve acid products; To solve the problem of sleep disorders in the middle-aged and elderly population, the company has launched a series of cicada flower cordyceps products. The matrix formed by the above products has been widely welcomed in the national market after being launched around 2023. As the main enterprise in the life and health industry chain of Wenzhou City, the "Cheng Yi sector" that serves the health cause of the middle-aged and elderly population nationwide has matured.
On November 17, 2023, Cheng Yi Health Zhejiang Center was established in Wenzhou
On November 17, 2023, Cheng Yi Pharmaceutical established the "Cheng Yi Health Zhejiang Center" in the urban area of Wenzhou, becoming a bridge and link between enterprises and the market, and promoting successful experiences nationwide. At the end of December, Ruicheng Biomedical Technology Co., Ltd., a subsidiary of Cheng Yi Pharmaceutical, cooperated with Shanghai Ruijin Hospital to develop and treat pancreatic cancer, a patented product - "disposable negative pressure drainage kit", signed the first order of market supply, successfully realizing patent conversion. Its subsidiary, Fujian Huakang Pharmaceutical, is actively building production conditions for 2000 tons of ammonia sugar raw materials annually. High quality and pure natural "green ammonia sugar" will gradually drive away chemical fermentation and enzymatic synthesis of ammonia sugar products, and contribute to "Healthy China". The Dendrobium officinale series products produced by another subsidiary, Guangzhou Sandaoyuan Pharmaceutical Technology Co., Ltd., are selling well in the southern region of China. The three subsidiaries are expected to provide more and better big health products to the national market in 2024, helping the national "silver economy" and serving the middle-aged and elderly population. (End)
Article source: China News Agency Zhejiang
Source link:https://m.chinanews.com/wap/detail/chs/zw/7633916hcxaxuvdf.shtml